(Q41470468)

1 October 2017

title

Inhibition of androgen binding in human foreskin fibroblasts by antiandrogens (English)

1 reference

1 October 2017

4

Migeon CJ

1 reference

1 October 2017

Brown TR

1

1 reference

1 October 2017

Rothwell SW

series ordinal

2

1 reference

1 October 2017

Sultan C

series ordinal

3

1 reference

1 October 2017

publication date

1 June 1981

1 reference

1 October 2017

1 reference

1 October 2017

volume

37

1 reference

1 October 2017

issue

6

1 reference

1 October 2017

page(s)

635-648

1 reference

Carcinoma of the prostate: treatment comparisons

1 October 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0039-128X%2881%2990173-2

7 January 2021

Relationship of Estrogen Therapy for Carcinoma of the Prostate to Atherosclerotic Cardiovascular Disease: A Clinicopathologic Study

1 reference

https://api.crossref.org/works/10.1016%2FS0039-128X%2881%2990173-2

7 January 2021

Carcinoma of the Prostate: Biopsy and Conservative Therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0039-128X%2881%2990173-2

7 January 2021

Effect of progestational agents on gonadal and adrenal cortical function in patients with benign prostatic hypertrophy and carcinoma of the prostate.

1 reference

https://api.crossref.org/works/10.1016%2FS0039-128X%2881%2990173-2

7 January 2021

Effects of the androgen antagonist cyproterone acetate on the testicular structure, spermatogenesis and accessory sexual glands of testosterone-treated adult hypophysectomized rats

1 reference

https://api.crossref.org/works/10.1016%2FS0039-128X%2881%2990173-2

7 January 2021

Some Endocrine Studies of a New Antiandrogen, 6 α-Bromo-17β-hydroxy-17α-methyl-4-oxa-5α:-androstan-3-one (BOMT)

1 reference

https://api.crossref.org/works/10.1016%2FS0039-128X%2881%2990173-2

7 January 2021

Experience in the Treatment of Prostatic Carcinoma with Cyproterone Acetate

1 reference

https://api.crossref.org/works/10.1016%2FS0039-128X%2881%2990173-2

7 January 2021

A biological profile of a nonsteroidal antiandrogen, SCH 13521 (4'-nitro-3'trifluoromethylisobutyranilide).

1 reference

https://api.crossref.org/works/10.1016%2FS0039-128X%2881%2990173-2

7 January 2021

SCH 13521 in the treatment of advanced carcinoma of the prostate.

1 reference

https://api.crossref.org/works/10.1016%2FS0039-128X%2881%2990173-2

7 January 2021

Prostatic Cancer and Sch-13521: II. Histological Alterations and the Pituitary Gonadal Axis

1 reference

https://api.crossref.org/works/10.1016%2FS0039-128X%2881%2990173-2

7 January 2021

Action of a non-steroid anti-androgen, RU 23908, in peripheral and central tissues

1 reference

https://api.crossref.org/works/10.1016%2FS0039-128X%2881%2990173-2

7 January 2021

Methyltrienolone, a specific ligand for cellular androgen receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0039-128X%2881%2990173-2

7 January 2021

Androgen receptor in human skin fibroblasts characterization of a specific 17β-hydroxy-5α-androstan-3-one-protein complex in cell sonicates and nuclei

1 reference

https://api.crossref.org/works/10.1016%2FS0039-128X%2881%2990173-2

7 January 2021

Partial androgen insensitivity: the Reifenstein syndrome revisited.

1 reference

https://api.crossref.org/works/10.1016%2FS0039-128X%2881%2990173-2

7 January 2021

A study of the conditions and mechanism of the diphenylamine reaction for the colorimetric estimation of deoxyribonucleic acid

1 reference

https://api.crossref.org/works/10.1016%2FS0039-128X%2881%2990173-2

7 January 2021

Intranuclear binding of [3H]dihydrotestosterone by cultured human fibroblasts

1 reference

https://api.crossref.org/works/10.1016%2FS0039-128X%2881%2990173-2

7 January 2021

Syndrome of androgen insensitivity in man: absence of 5 alpha-dihydrotestosterone binding protein in skin fibroblasts

1 reference

https://api.crossref.org/works/10.1016%2FS0039-128X%2881%2990173-2

7 January 2021

Neo-nuclear androgen receptor in rat ventral prostate.

1 reference

https://api.crossref.org/works/10.1016%2FS0039-128X%2881%2990173-2

7 January 2021

An explanatiom of the antiandrogenic properties of 6α-bromo-17β-hydroxy-17α-methyl-4-oxa-5α-androstane-3-one

1 reference

https://api.crossref.org/works/10.1016%2FS0039-128X%2881%2990173-2

7 January 2021

Effect of 17-alpha-methyl-beta-nortestosterone (SK & F 7690) on the binding in vitro of 5-alpha-dihydrotestosterone to macromolecular components from the rat ventral prostate

1 reference

https://api.crossref.org/works/10.1016%2FS0039-128X%2881%2990173-2

7 January 2021

Mode of spironolactone anti-androgenic action: inhibition of androstanolone binding to rat prostate androgen receptor.

1 reference

https://api.crossref.org/works/10.1016%2FS0039-128X%2881%2990173-2

7 January 2021

On the Mechanism of the Anti-androgenic Action ofFlutamide (α-α-α-Trifluoro-2-methyl-4'-nitro-m-propionotoluidide)in the Rat

1 reference

https://api.crossref.org/works/10.1016%2FS0039-128X%2881%2990173-2

7 January 2021

Action of a nonsteroidal antiandrogen, flutamide, on the receptor binding and nuclear retention of 5 alpha-dihydrotestosterone in rat ventral prostate

1 reference

https://api.crossref.org/works/10.1016%2FS0039-128X%2881%2990173-2

7 January 2021

An investigation into the anti-androgenic properties of the non-steroidal compound, sch 13521 (4′-nitro-3′-trifluoromethylisobutyrylanilide)

1 reference

https://api.crossref.org/works/10.1016%2FS0039-128X%2881%2990173-2

7 January 2021

Selective inhibition by secosteroids of 5α-reductase activity in human sex skin fibroblasts

1 reference

https://api.crossref.org/works/10.1016%2FS0039-128X%2881%2990173-2

7 January 2021

10.1016/S0039-128X(81)90173-2

Identifiers

DOI

1 reference

1 October 2017

1 reference